Jones Financial Companies
ONC

Jones Financial Companies’s BeOne Medicines Ltd ONC Stock Holding History

Jones Financial Companies’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.92M Buy
6,865
+400
+6% +$118K ﹤0.01% 1600
2026
Q1 		$1.83M Buy
6,465
+6,275
+3,303% +$2.03M ﹤0.01% 1467
2025
Q4 		$57.7K Buy
190
+100
+111% +$32.7K ﹤0.01% 2449
2025
Q3 		$29.3K Sell
90
-273
-75% -$82.9K ﹤0.01% 2601
2025
Q2 		$87.6K Buy
363
+353
+3,530% +$86.6K ﹤0.01% 1987
2025
Q1 		$2.67K Hold
10
– – ﹤0.01% 3175
2024
Q4 		$1.85K Buy
10
+5
+100% +$1.02K ﹤0.01% 3020
2024
Q3 		$1.09K Sell
5
-6
-55% -$1.08K ﹤0.01% 2793
2024
Q2 		$1.57K Buy
+11
New +$1.7K ﹤0.01% 2209
2024
Q1 		– Sell
-2
Closed -$361 – 1457
2023
Q4 		$361 Buy
+2
New +$362 ﹤0.01% 999
2022
Q1 		– Sell
-8
Closed -$2K – 861
2021
Q4 		$2K Buy
+8
New +$2.7K ﹤0.01% 727

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Jones Financial Companies's ONC Position: Q2 2026 in Review

Jones Financial Companies increased its BeOne Medicines Ltd (ONC) stake by 6.2% in Q2 2026, buying an estimated $118K and bringing the position to 6,865 shares worth $1.92M. The position accounts for ﹤0.01% of the portfolio, ranked #1600.

Jones Financial Companies first reported a position in ONC in Q4 2021 and has held it in 11 quarters since. 282 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Jones Financial Companies held 6,865 shares of BeOne Medicines Ltd worth $1.92M as of Q2 2026.
  • Jones Financial Companies bought 400 BeOne Medicines Ltd shares in Q2 2026, an estimated $118K.
  • BeOne Medicines Ltd made up ﹤0.01% of Jones Financial Companies's portfolio in Q2 2026, its #1600 holding.
  • Jones Financial Companies first reported a position in BeOne Medicines Ltd in Q4 2021 and has held it in 11 quarters since.
  • 282 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Jones Financial Companies's 13F filing for Q2 2026, filed 14 Aug 2026.